recurrent ovarian cancer

Research Reports

Resource Utilization and Expenditures During the “Watchful Waiting” Period in Patients With Recurrent Ovarian Cancer

02/19/2019

Karin Travers , DSc;

Adrienne M. Gilligan , PhD;

Paula Smith , MS;

Paul Juneau , MS;

Mohan Bala , PhD;

Brian M. Davis , PhD;

Brooke Harrow , PhD;

Abstract: This article aims to quantify the use of health services during the watchful waiting period after second-line platinum-based therapy among patients with ovarian cancer. Women newly diagnosed with ovarian,...

...

02/19/2019

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

recurrent ovarian cancer

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products